Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 ...

The move will place students in good stead to take up skilled roles in biopharma manufacturing. Read more at straitstimes.com ...

Two Philadelphia biotech companies scored approval in 2024 for first-of-their-kind gene therapy treatments for solid cancer ...